By Mark Wade, Global Practice Leader COA, TransPerfect Life Sciences
As more and more eClinical companies broadened their offerings to encompass more aspects of a complete study it would only be natural to include in their arsenal an eCOA solution. Unfortunately, such a solution is significantly more complex than virtually all other “e” offerings. Moreover, direct patient data (selfreported) is more guarded by Study teams than any aspect of the study process.
Selecting and deploying a new eCOA solution involves many important factors—from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration—and it’s impossible not to worry about missing a key detail in the process. Download our whitepaper to learn about the eCOA landscape today, and access a checklist that walks through each of the essential factors to consider so you can be confident your eCOA implementation partnership is a success.